In the BioHarmony Drug Report Database

"Preview" Icon

Diazoxide

Hyperstat, Proglycem (diazoxide) is a small molecule pharmaceutical. Diazoxide was first approved as Hyperstat on 1982-01-01. It is used to treat hypoglycemia and malignant hypertension in the USA. It is known to target ATP-sensitive inward rectifier potassium channel 8, ATP-sensitive inward rectifier potassium channel 11, and nicotinamide phosphoribosyltransferase.

 

Trade Name

 

Hyperstat, Proglycem
 

Common Name

 

diazoxide
 

ChEMBL ID

 

CHEMBL181
 

Indication

 

hypoglycemia, malignant hypertension
 

Drug Class

 

Image (chem structure or protein)

Diazoxide structure rendering